COGSTATE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.325 AUD | +2.71% |
|
+6.43% | -8.30% |
| Apr. 01 | Cogstate Amends License Agreement with Eisai for Alzheimer’s Treatment | MT |
| Feb. 22 | Cogstate's Fiscal H1 Attributable Profit Jumps, Revenue Rises 3%; Shares Decline 8% | MT |
Presenter SpeechMartyn Myer (Executives)Since the inception of Cogstate in 1999, our investmen...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Cogstate Ltd is a neuroscience technology company. It is engaged in the creation, validation, and commercialization of digital brain health assessments and design and assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Research. The Clinical Trials segment includes adoption of decentralized clinical trial methodologies and scientific publication and marketing of the utility and validity of Cogstate technology. The Healthcare segment includes Cognigram, which allows for regular and standardized testing to assist in the early detection of cognitive decline that could be related to a range of factors including head injury, neurodegenerative disease or side effects following pharmacological treatments. The Research segment includes research studies and academic collaborations across various indications, such as Alzheimerâs disease and Parkinsonâs disease.
Calendar
2024-08-21
- Q4 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.325
AUD
Average target price
1.8
AUD
Spread / Average Target
+35.85%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -8.30% | 147M | |
| +0.78% | 43.84B | |
| +4.68% | 41.68B | |
| +45.55% | 41.25B | |
| -10.92% | 27.04B | |
| +7.00% | 25.53B | |
| -25.68% | 18.18B | |
| -4.13% | 12.29B | |
| +25.15% | 12.29B | |
| +6.83% | 11.15B |
- Stock Market
- Equities
- CGS Stock
- News Cogstate Limited
- Transcript : Cogstate Limited - Shareholder/Analyst Call
